GB1325797A
(en)
|
1970-09-24 |
1973-08-08 |
Upjohn Co |
Medicines comprising cytidine derivatives
|
GB1386334A
(en)
|
1972-09-22 |
1975-03-05 |
Kohjin Co |
2,2-cyclocytidine derivatives
|
FR2252851B1
(es)
|
1973-11-29 |
1978-07-21 |
Kohjin Co |
|
US4096324A
(en)
|
1975-07-07 |
1978-06-20 |
The Upjohn Company |
Cytidine nucleoside compound
|
US5736531A
(en)
|
1987-10-28 |
1998-04-07 |
Pro-Neuron, Inc. |
Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
|
US5470838A
(en)
|
1987-10-28 |
1995-11-28 |
Pro-Neuron, Inc. |
Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
|
JPH05500799A
(ja)
|
1989-06-05 |
1993-02-18 |
ギリアド サイエンシス,インコーポレイテッド |
エキソヌクレアーゼ抵抗性オリゴヌクレオチドおよびその調製方法
|
EP0558634A4
(en)
|
1990-11-23 |
1995-06-28 |
Gilead Sciences Inc |
Triplex-forming oligomers containing modified bases
|
FI105556B
(fi)
|
1991-09-30 |
2000-09-15 |
Sankyo Co |
Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta
|
HU225970B1
(en)
|
1991-10-11 |
2008-01-28 |
Acad Of Science Czech Republic |
Antiviral acyclic phosphonomethoxyalkyl-substituted alkenyl purine and pyrimidine derivatives, and pharmaceutical preparations containing them
|
DE69232816T2
(de)
|
1991-11-26 |
2003-06-18 |
Isis Pharmaceuticals, Inc. |
Gesteigerte bildung von triple- und doppelhelices aus oligomeren mit modifizierten pyrimidinen
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
IS2334B
(is)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
AU6632094A
(en)
|
1993-04-19 |
1994-11-08 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
US5349947A
(en)
|
1993-07-15 |
1994-09-27 |
Newhouse Michael T |
Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
|
JPH09506333A
(ja)
|
1993-09-17 |
1997-06-24 |
ギリアード サイエンシーズ,インコーポレイテッド |
治療化合物の投薬方法
|
CA2171743C
(en)
|
1993-09-17 |
2007-11-20 |
Norbert W. Bischofberger |
Nucleotide analogs
|
BR9607098A
(pt)
|
1995-02-27 |
1997-11-04 |
Gilead Sciences Inc |
Novos inibidores seletivos de neuraminidas virais ou bacterianas
|
US6043358A
(en)
|
1995-11-01 |
2000-03-28 |
Merck & Co., Inc. |
Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
|
CA2268756A1
(en)
|
1996-10-21 |
1998-04-30 |
Gilead Sciences, Inc. |
Piperidine compounds
|
GB9718913D0
(en)
|
1997-09-05 |
1997-11-12 |
Glaxo Group Ltd |
Substituted oxindole derivatives
|
US6086376A
(en)
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
CN1315862C
(zh)
|
2000-05-26 |
2007-05-16 |
艾登尼科斯(开曼)有限公司 |
处理黄病毒和瘟病毒的方法和组合物
|
US20030008841A1
(en)
*
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
PT2251015E
(pt)
|
2000-10-18 |
2013-04-15 |
Gilead Pharmasset Llc |
Nucleosídeos modificados para o tratamento de infeções virais e de proliferação celular anormal
|
CA2743451A1
(en)
*
|
2000-10-18 |
2002-04-25 |
Pharmasset, Inc. |
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
|
NZ561342A
(en)
|
2000-10-18 |
2010-02-26 |
Pharmasset Inc |
Simultaneous quantification of nucleic acids in diseased cells
|
ES2327397T3
(es)
|
2001-04-30 |
2009-10-29 |
TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL |
Esteres de uridina farmaceuticamente activos.
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
US7049303B2
(en)
|
2001-11-07 |
2006-05-23 |
Medical Research Council |
Inhibition of viruses
|
UA80819C2
(en)
|
2002-04-26 |
2007-11-12 |
Gilead Sciences Inc |
Phosphonate analogs of compounds inhibiting hiv proteases, pharmaceutical composition on their basis and their use
|
US20050239054A1
(en)
|
2002-04-26 |
2005-10-27 |
Arimilli Murty N |
Method and compositions for identifying anti-HIV therapeutic compounds
|
GB0215293D0
(en)
|
2002-07-03 |
2002-08-14 |
Rega Foundation |
Viral inhibitors
|
JP4806187B2
(ja)
|
2002-07-15 |
2011-11-02 |
ギリード・サイエンシズ・インコーポレーテッド |
B型肝炎ウイルスの治療のためのl−fmauとの併用療法
|
WO2004024185A1
(ja)
|
2002-09-11 |
2004-03-25 |
Michio Ishibashi |
医薬または化粧料
|
US20040191763A1
(en)
|
2002-10-01 |
2004-09-30 |
Gilead Sciences, Inc. |
HBV mutations associated with reduced susceptibility to adefovir
|
AU2003301439A1
(en)
|
2002-10-16 |
2004-05-04 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
AU2003287606A1
(en)
|
2002-11-12 |
2004-06-03 |
Enzon Pharmaceuticals, Inc. |
Novel acylating reagents
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
AU2003297612A1
(en)
|
2002-12-02 |
2004-06-23 |
Gilead Sciences, Inc. |
2-substituted-3-propenamide derivatives and methods of using the same
|
JP2006515624A
(ja)
|
2003-01-14 |
2006-06-01 |
ギリアード サイエンシーズ, インコーポレイテッド |
組み合わせ抗ウイルス療法のための組成物および方法
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
EP1663254A2
(en)
|
2003-04-25 |
2006-06-07 |
Gilead Sciences, Inc. |
Anti-inflamatory phosphonate conjugates
|
CN101410120A
(zh)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
NZ542342A
(en)
|
2003-04-25 |
2009-05-31 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US20060252729A1
(en)
|
2003-07-30 |
2006-11-09 |
Krawczyk Steven H |
Nucleobase phosphonate analogs for antiviral treatment
|
EP1664046B1
(en)
|
2003-09-19 |
2009-06-17 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
RU2264409C2
(ru)
|
2003-10-01 |
2005-11-20 |
Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") |
2`-амино-2`-дезоксинуклеозиды - ингибиторы репродукции вирусов кори и марбург
|
EP1678321A1
(en)
|
2003-10-24 |
2006-07-12 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
EP1680435A1
(en)
|
2003-11-03 |
2006-07-19 |
Cognis IP Management GmbH |
Acyl ribonucleosides and acyl deoxyribonucleosides
|
AU2004309390B2
(en)
|
2003-12-22 |
2011-06-02 |
Gilead Sciences, Inc. |
Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
|
CA2548753A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
4-substituted carbovir and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
|
ES2350983T3
(es)
|
2003-12-30 |
2011-01-28 |
Gilead Sciences, Inc. |
Fosfonatos, monofosfonamidatos, bisfosfonamidatos para el tratamiento de enfermedades víricas.
|
WO2005070901A2
(en)
|
2004-01-12 |
2005-08-04 |
Gilead Sciences, Inc. |
Pyrimidyl phosphonate antiviral compounds and methods of use
|
US20050239753A1
(en)
|
2004-01-21 |
2005-10-27 |
Gilead Sciences, Inc. |
Methods of inhibition of MMTV-like viruses
|
ATE411030T1
(de)
|
2004-04-14 |
2008-10-15 |
Gilead Sciences Inc |
Phosphonatanaloga von hiv- integrasehemmerverbindungen
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
KR20070034119A
(ko)
|
2004-07-16 |
2007-03-27 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 화합물
|
CA2574220C
(en)
|
2004-07-27 |
2014-09-16 |
Gilead Sciences, Inc. |
Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
|
EP1778251B1
(en)
|
2004-07-27 |
2011-04-13 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates as anti hiv agents
|
DE102004051804A1
(de)
*
|
2004-10-21 |
2006-04-27 |
Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) |
Beta-L-N4-Hydroxycytosin-Desoxynucleoside und ihre Verwendung als pharmazeutische Mittel zur Prophylaxe oder Therapie von viralen Erkrankungen
|
CA2585353A1
(en)
|
2004-10-26 |
2006-05-04 |
Gilead Sciences, Inc. |
Phosphonate derivatives of mycophenolic acid
|
ATE426601T1
(de)
|
2004-12-21 |
2009-04-15 |
Gilead Sciences Inc |
Imidazoa4,5-cupyridinverbindung und verfahren zur antiviralen behandlung
|
WO2006091905A1
(en)
|
2005-02-25 |
2006-08-31 |
Gilead Sciences, Inc. |
Bicyclo (3.1.0) hexane derivatives as antiviral compounds
|
AR057023A1
(es)
|
2005-05-16 |
2007-11-14 |
Gilead Sciences Inc |
Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
|
EP2526942B1
(en)
|
2005-06-08 |
2017-08-09 |
The University of North Carolina At Chapel Hill |
Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
|
TW200738742A
(en)
|
2005-07-14 |
2007-10-16 |
Gilead Sciences Inc |
Antiviral compounds
|
TWI389908B
(zh)
|
2005-07-14 |
2013-03-21 |
Gilead Sciences Inc |
抗病毒化合物類
|
WO2007014174A2
(en)
|
2005-07-25 |
2007-02-01 |
Gilead Sciences, Inc. |
Drug-resistant mutants of hepatitis c virus
|
WO2007014352A2
(en)
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
US7589101B2
(en)
|
2005-08-16 |
2009-09-15 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
JP4885963B2
(ja)
|
2005-09-22 |
2012-02-29 |
エフ.ホフマン−ラ ロシュ アーゲー |
ヌクレオシドの選択的o−アシル化
|
CA2635468C
(en)
|
2005-12-30 |
2016-08-09 |
Gilead Sciences, Inc. |
Methods for improving the pharmacokinetics of hiv integrase inhibitors
|
UA97241C2
(uk)
|
2006-03-29 |
2012-01-25 |
Гіліад Сайєнсіз, Інк. |
Спосіб одержання інгібіторів віл-протеази
|
WO2008003149A2
(en)
|
2006-07-06 |
2008-01-10 |
Gilead Sciences , Inc. |
Substituted pteridines for the treatment and prevention of viral infections
|
DE602007004220D1
(de)
|
2006-07-07 |
2010-02-25 |
Leuven K U Res & Dev |
Neue pyridazinverbindung und ihre verwendung
|
WO2008005542A2
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc., |
Antiviral phosphinate compounds
|
TWI399377B
(zh)
|
2006-07-07 |
2013-06-21 |
Gilead Sciences Inc |
類鐸受體7之調節劑
|
EP3696171A1
(en)
|
2006-07-07 |
2020-08-19 |
Gilead Sciences, Inc. |
Modulators of pharmacokinetic properties of therapeutics
|
WO2008009079A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
Substituted pteridines useful for the treatment and prevention of viral infections
|
WO2008009077A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
WO2008009078A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
US8338435B2
(en)
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
NZ573887A
(en)
|
2006-07-21 |
2012-02-24 |
Gilead Sciences Inc |
Antiviral protease inhibitors
|
NZ573888A
(en)
|
2006-07-21 |
2012-02-24 |
Gilead Sciences Inc |
Aza-peptide protease inhibitors
|
US20090312318A1
(en)
|
2006-07-24 |
2009-12-17 |
Desai Manoj C |
Therapeutic compounds and methods
|
UA95955C2
(ru)
|
2006-07-24 |
2011-09-26 |
Кореа Ресерч Инститьют Оф Кемикал Текнолоджи |
Ингибиторы обратной транскриптазы вич
|
BRPI0719445A2
(pt)
|
2006-09-27 |
2013-12-10 |
Coley Pharm Group Inc |
Composições de ligandos de tlr e antivirais.
|
JP5639762B2
(ja)
|
2006-12-14 |
2014-12-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
ウイルス阻害剤
|
US8637531B2
(en)
|
2006-12-26 |
2014-01-28 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyridmidines useful for treating viral infections
|
WO2008077649A1
(en)
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infectons
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
US8324179B2
(en)
|
2007-02-09 |
2012-12-04 |
Gilead Sciences, Inc. |
Nucleoside analogs for antiviral treatment
|
HUE029866T2
(en)
|
2007-02-23 |
2017-03-28 |
Gilead Sciences Inc |
Modulation of pharmacokinetic parameters of therapeutic agents
|
CN101668515B
(zh)
*
|
2007-03-29 |
2013-03-20 |
弗·哈夫曼-拉罗切有限公司 |
药物组合物和方法
|
EA200971093A1
(ru)
|
2007-06-29 |
2010-08-30 |
Джилид Сайэнс, Инк. |
Терапевтические композиции и их применение
|
CA2692145C
(en)
|
2007-06-29 |
2015-03-03 |
Gilead Sciences, Inc. |
Antiviral compounds
|
PT2170888E
(pt)
|
2007-06-29 |
2015-08-21 |
Gilead Sciences Inc |
Purina derivados e sua utilização como moduladores de recetor de tipo toll 7
|
MX2009013827A
(es)
|
2007-06-29 |
2010-03-01 |
Gilead Sciences Inc |
Compuestos antivirales.
|
AR067180A1
(es)
|
2007-06-29 |
2009-09-30 |
Gilead Sciences Inc |
Compuestos antivirales
|
WO2009005693A1
(en)
|
2007-06-29 |
2009-01-08 |
Gilead Sciences, Inc. |
Novel hiv reverse transcriptase inhibitors
|
JP5547067B2
(ja)
|
2007-06-29 |
2014-07-09 |
ギリアード サイエンシーズ, インコーポレイテッド |
治療組成物およびその使用
|
MX2009013804A
(es)
|
2007-06-29 |
2010-02-03 |
Korea Res Inst Chem Tech |
Inhibidores novedosos de transcriptasa inversa de vih.
|
UA99466C2
(en)
|
2007-07-06 |
2012-08-27 |
Гилиад Сайенсиз, Инк. |
Crystalline pyridazine compound
|
WO2009058800A2
(en)
|
2007-10-29 |
2009-05-07 |
President And Fellows Of Harvard College |
Synthesis of nucleosides
|
US20100298256A1
(en)
|
2007-12-27 |
2010-11-25 |
Steven Dong |
Antiviral compounds
|
PT2231628E
(pt)
|
2008-01-04 |
2015-12-29 |
Gilead Sciences Inc |
Inibidores de citocromo p450
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
RS54008B1
(en)
|
2008-04-23 |
2015-10-30 |
Gilead Sciences Inc. |
1`-SUBSTITUTED CARBA-NUCLEOSIDE ANALYSIS FOR ANTI-VIRUS THERAPY
|
WO2009143011A1
(en)
|
2008-05-20 |
2009-11-26 |
Novartis Ag |
Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
|
US8536187B2
(en)
|
2008-07-03 |
2013-09-17 |
Gilead Sciences, Inc. |
2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
|
BRPI0915878A2
(pt)
|
2008-07-08 |
2015-11-03 |
Gilead Sciences Inc |
sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
|
JP2011529085A
(ja)
|
2008-07-25 |
2011-12-01 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス化合物
|
TWI534136B
(zh)
|
2008-12-09 |
2016-05-21 |
吉李德科學股份有限公司 |
用於製備可用作類鐸受體調節劑之化合物的中間體化合物
|
CN102300871A
(zh)
|
2008-12-19 |
2011-12-28 |
吉里德科学公司 |
Hcv ns3蛋白酶抑制剂
|
UY32332A
(es)
|
2008-12-22 |
2010-07-30 |
Gilead Sciences Inc |
Compuestos macrocíclicos sus prodrogas, n-óxidos, sales de adición, aminas cuaternarias, complejos de metales y formas estereoquímicamente isoméricas puras.
|
JP5746638B2
(ja)
|
2009-02-10 |
2015-07-08 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス処置のためのカルバ−ヌクレオシドアナログ
|
CN104211713B
(zh)
|
2009-05-13 |
2017-04-12 |
吉利德制药有限责任公司 |
抗病毒化合物
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
UY32715A
(es)
|
2009-06-23 |
2011-01-31 |
Gilead Sciences Inc |
Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados
|
TW201113279A
(en)
|
2009-06-23 |
2011-04-16 |
Gilead Sciences Inc |
Pharmaceutical compositions useful for treating HCV
|
WO2010151488A1
(en)
|
2009-06-23 |
2010-12-29 |
Gilead Sciences, Inc. |
Combination of boceprevir with 5- ( { 6- [2, 4- bis (trifluoromethyl) phenyl] pyridazin-3 -yl } methyl) -2- (2 -fluorophenyl) -5h- imidazo [4, 5-c] pyridine for the treatment of hcv
|
WO2011005842A1
(en)
|
2009-07-09 |
2011-01-13 |
Gilead Sciences, Inc. |
Anti-rsv compounds
|
PE20120666A1
(es)
|
2009-07-21 |
2012-06-01 |
Gilead Sciences Inc |
Inhibidores de los virus flaviviridae
|
CA2771124C
(en)
|
2009-09-09 |
2019-01-15 |
Gilead Sciences, Inc. |
Inhibitors of flaviviridae viruses
|
ES2661850T3
(es)
|
2009-09-14 |
2018-04-04 |
Gilead Sciences, Inc. |
Moduladores de receptores del tipo toll
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
PE20120995A1
(es)
|
2009-09-21 |
2012-08-01 |
Gilead Sciences Inc |
Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral
|
US8962652B2
(en)
|
2009-10-22 |
2015-02-24 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
US20110150836A1
(en)
|
2009-12-22 |
2011-06-23 |
Gilead Sciences, Inc. |
Methods of treating hbv and hcv infection
|
TWI491609B
(zh)
|
2010-01-15 |
2015-07-11 |
Gilead Sciences Inc |
黃熱病毒科(Flaviviridae)病毒之抑制劑類
|
AU2011205797B2
(en)
|
2010-01-15 |
2015-07-16 |
Gilead Sciences, Inc. |
Inhibitors of Flaviviridae viruses
|
KR101384389B1
(ko)
|
2010-01-28 |
2014-04-10 |
에프. 호프만-라 로슈 아게 |
항-hcv 화합물로서의 4''-아지도-뉴클레오시드
|
US20110223131A1
(en)
|
2010-02-24 |
2011-09-15 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US8367829B2
(en)
|
2010-05-10 |
2013-02-05 |
Gilead Sciences, Inc. |
Bi-functional pyrazolopyridine compounds
|
EP2569285A1
(en)
|
2010-05-10 |
2013-03-20 |
Gilead Sciences, Inc. |
Bifunctional quinoline derivatives
|
CA2797872A1
(en)
|
2010-05-21 |
2011-11-24 |
Gilead Sciences, Inc. |
Heterocyclic flaviviridae virus inhibitors
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
TW201210597A
(en)
|
2010-06-09 |
2012-03-16 |
Gilead Sciences Inc |
Inhibitors of hepatitis C virus
|
WO2011156757A1
(en)
|
2010-06-10 |
2011-12-15 |
Gilead Sciences, Inc. |
Combination of anti-hcv compounds with ribavirin for the treatment of hcv
|
CN103079561B
(zh)
|
2010-06-11 |
2015-12-02 |
吉里德科学公司 |
用于预防hsv-2传播的局部用抗病毒制剂
|
SG10201505022WA
(en)
|
2010-06-24 |
2015-07-30 |
Gilead Sciences Inc |
Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
|
US9102614B2
(en)
|
2010-07-02 |
2015-08-11 |
Gilead Sciences, Inc. |
Naphth-2-ylacetic acid derivatives to treat AIDS
|
US9296758B2
(en)
|
2010-07-02 |
2016-03-29 |
Gilead Sciences, Inc. |
2-quinolinyl-acetic acid derivatives as HIV antiviral compounds
|
KR102108864B1
(ko)
|
2010-07-19 |
2020-05-12 |
길리애드 사이언시즈, 인코포레이티드 |
부분입체 이성질성으로 순수한 포스포라미데이트 전구약물의 제조 방법
|
UA111163C2
(uk)
|
2010-07-22 |
2016-04-11 |
Гайлід Сайєнсіз, Інк. |
Способи й сполуки для лікування вірусних інфекцій paramyxoviridae
|
CN102351931B
(zh)
|
2010-09-07 |
2014-01-22 |
河南省科学院高新技术研究中心 |
嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
NZ608070A
(en)
|
2010-09-20 |
2015-11-27 |
Gilead Sciences Inc |
2’-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
KR20200140924A
(ko)
|
2010-11-17 |
2020-12-16 |
길리애드 파마셋 엘엘씨 |
항바이러스 화합물
|
PL2640362T5
(pl)
|
2010-11-19 |
2022-05-02 |
Gilead Sciences, Inc. |
Kompozycje terapeutyczne zawierające hcl rylpiwiryny i fumaran dizoproksylu tenofowiru
|
AR084217A1
(es)
|
2010-12-10 |
2013-05-02 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
JP5891241B2
(ja)
|
2010-12-20 |
2016-03-22 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hcvを処置するための組合せ
|
WO2012088153A1
(en)
|
2010-12-21 |
2012-06-28 |
Gilead Sciences, Inc. |
Inhibitors of cytochrome p450
|
US8987313B2
(en)
|
2010-12-21 |
2015-03-24 |
Gilead Sciences, Inc. |
Inhibitors of cytochrome P450
|
WO2012088178A1
(en)
|
2010-12-21 |
2012-06-28 |
Gilead Sciences, Inc. |
Inhibitors of cytochrome p450 (cyp3a4)
|
TW201302760A
(zh)
|
2011-04-04 |
2013-01-16 |
Gilead Sciences Inc |
製備hiv整合酶抑制劑之方法
|
CA2830845A1
(en)
|
2011-04-04 |
2012-10-11 |
Gilead Sciences, Inc. |
Solid state forms of hiv inhibitor
|
EP2697241B1
(en)
|
2011-04-13 |
2019-06-12 |
Gilead Sciences, Inc. |
1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
|
CN103797001B
(zh)
|
2011-04-21 |
2016-04-20 |
吉利德科学公司 |
苯并噻唑化合物及其药学上的应用
|
JP2014513123A
(ja)
|
2011-05-02 |
2014-05-29 |
ギリアード サイエンシーズ, インコーポレイテッド |
無定形固体の塩
|
EP2729490A1
(en)
|
2011-07-06 |
2014-05-14 |
Gilead Sciences, Inc. |
Hcv genotype 4 replicons
|
EP2729489A1
(en)
|
2011-07-06 |
2014-05-14 |
Gilead Sciences, Inc. |
Hcv genotype 3 replicons
|
US9540343B2
(en)
|
2011-07-06 |
2017-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of HIV
|
PT2734515E
(pt)
|
2011-07-13 |
2016-03-11 |
Gilead Sciences Inc |
Derivados de ácido tiofen-2-carboxílico úteis como inibidores de vírus flaviviridae
|
MX336627B
(es)
|
2011-08-16 |
2016-01-26 |
Gilead Sciences Inc |
Hemifumarato de tenofovir alafenamida.
|
RS56975B1
(sr)
|
2011-09-16 |
2018-05-31 |
Gilead Pharmasset Llc |
Metode za lečenje hcv-a
|
EP2776024A1
(en)
|
2011-10-31 |
2014-09-17 |
Gilead Pharmasset LLC |
Methods and compositions for treating hepatitis c virus
|
PT3431477T
(pt)
|
2011-11-16 |
2020-12-15 |
Gilead Pharmasset Llc |
Imidazolilimidazolos condensados como compostos antivirais
|
ES2817886T3
(es)
|
2011-11-29 |
2021-04-08 |
Gilead Pharmasset Llc |
Composiciones y métodos para tratar el virus de la hepatitis C
|
WO2013090840A1
(en)
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
2 -amino- pyrido [3, 2 -d] pyrimidine derivatives as hcv inhibitors
|
WO2013090929A1
(en)
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
Amino quinoline derivatives inhibitors of hcv
|
US20130157973A1
(en)
|
2011-12-20 |
2013-06-20 |
Gilead Sciences, Inc. |
Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders
|
EP2794627B1
(en)
|
2011-12-22 |
2018-09-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
JP6122868B2
(ja)
|
2011-12-22 |
2017-04-26 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス剤としてのピラゾロ[1,5−a]ピリミジン
|
AU2013235220C1
(en)
|
2011-12-22 |
2019-03-28 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9284323B2
(en)
|
2012-01-04 |
2016-03-15 |
Gilead Sciences, Inc. |
Naphthalene acetic acid derivatives against HIV infection
|
US9376392B2
(en)
|
2012-01-04 |
2016-06-28 |
Gilead Sciences, Inc. |
2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
|
EP2802315A1
(en)
|
2012-01-12 |
2014-11-19 |
Gilead Sciences, Inc. |
Pharmaceutical compositions and methods for their preparation
|
MD20140091A2
(ro)
|
2012-02-03 |
2015-01-31 |
Gilead Sciences, Inc. |
Terapie combinată cuprinzând hemifumarat tenofovir alafenamidă şi cobicistat pentru utilizare în tratamentul infecţiilor virale
|
WO2013115916A1
(en)
|
2012-02-03 |
2013-08-08 |
Gilead Sciences, Inc. |
Combination therapy comprising gs-7340 and cobicistat for use in the treatment of viral infections
|
EP2834258B1
(en)
|
2012-03-13 |
2017-01-04 |
Gilead Sciences, Inc. |
2'- substituted carba-nucleoside analogs for antiviral treatment
|
PL2838900T3
(pl)
|
2012-04-17 |
2020-02-28 |
Gilead Sciences, Inc. |
Związki i sposoby do leczenia przeciwwirusowego
|
CA2850881C
(en)
|
2012-04-20 |
2021-02-16 |
Gilead Sciences, Inc. |
Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
|
US9079887B2
(en)
|
2012-05-16 |
2015-07-14 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
MX2014014768A
(es)
|
2012-06-08 |
2015-05-11 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae.
|
NZ724503A
(en)
|
2012-06-08 |
2017-12-22 |
Gilead Sciences Inc |
Macrocyclic inhibitors of flaviviridae viruses
|
UA119315C2
(uk)
|
2012-07-03 |
2019-06-10 |
Гіліад Фармассет Елелсі |
Інгібітори вірусу гепатиту с
|
US8841340B2
(en)
|
2012-08-17 |
2014-09-23 |
Gilead Sciences, Inc. |
Solid forms of an antiviral compound
|
WO2014055618A1
(en)
|
2012-10-03 |
2014-04-10 |
Gilead Sciences, Inc. |
Solid state forms of hiv inhibitor: hemi-succinate of (2s)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid)
|
WO2014064588A2
(en)
|
2012-10-26 |
2014-05-01 |
Koninklijke Philips N.V. |
Autostereoscopic display device having a see-through mode of operation.
|
KR20150090894A
(ko)
|
2012-10-29 |
2015-08-06 |
코크리스탈 파마, 아이엔씨. |
바이러스 감염 및 암 치료용 피리미딘 뉴클레오티드 및 그들의 모노포스페이트 프로드럭
|
JP2016500700A
(ja)
|
2012-10-30 |
2016-01-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
リシルオキシダーゼ様2(loxl2)に関する治療および診断方法
|
EP2917340A1
(en)
|
2012-11-07 |
2015-09-16 |
Gilead Sciences, Inc. |
Hcv genotype 6 replicons
|
EP2935304A1
(en)
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
LT2935303T
(lt)
|
2012-12-21 |
2021-03-25 |
Janssen Biopharma, Inc. |
4'-fluor-nukleozidai, 4'-fluor-nukleotidai ir jų analogai, skirti hcv gydymui
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
SI3608325T1
(sl)
|
2012-12-21 |
2022-09-30 |
Gilead Sciences, Inc. |
Policiklične-karbamoilpiridonske spojine in njihova farmacevtska uporaba
|
NZ631762A
(en)
|
2013-01-09 |
2017-02-24 |
Gilead Sciences Inc |
5-membered heteroaryls and their use as antiviral agents
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
AU2014205315B2
(en)
|
2013-01-09 |
2016-11-17 |
Gilead Sciences, Inc. |
Therapeutic compounds for the treatment of viral infections
|
WO2014124430A1
(en)
|
2013-02-11 |
2014-08-14 |
Emory University |
Nucleotide and nucleoside therapeutic compositions and uses related thereto
|
TWI706945B
(zh)
|
2013-03-01 |
2020-10-11 |
美商基利科學股份有限公司 |
供治療反轉錄病毒科病毒感染之治療性化合物
|
US20140273023A1
(en)
|
2013-03-15 |
2014-09-18 |
Saladax Biomedical Inc. |
Gemcitabine immunoassay
|
EP2970335B1
(en)
|
2013-03-15 |
2019-05-08 |
Gilead Sciences, Inc. |
Macrocyclic and bicyclic inhibitors of hepatitis c virus
|
WO2014165542A1
(en)
|
2013-04-01 |
2014-10-09 |
Idenix Pharmaceuticals, Inc. |
2',4'-fluoro nucleosides for the treatment of hcv
|
BR112015025716A2
(pt)
|
2013-04-12 |
2017-07-18 |
Achillion Pharmaceuticals Inc |
pró-fármacos de nucleosídeo submetidos a deutério úteis para o tratamento de hcv
|
US9895442B2
(en)
|
2013-05-16 |
2018-02-20 |
Riboscience Llc |
4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
|
EP3013340B9
(en)
|
2013-06-26 |
2023-10-04 |
Janssen Pharmaceuticals, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2015023893A1
(en)
|
2013-08-16 |
2015-02-19 |
Gilead Sciences, Inc. |
Hcv genotype 4d replicons
|
EP3043803B1
(en)
|
2013-09-11 |
2022-04-27 |
Emory University |
Nucleotide and nucleoside compositions and their uses
|
MX2016004558A
(es)
|
2013-10-11 |
2016-07-06 |
Alios Biopharma Inc |
Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
WO2015084741A2
(en)
|
2013-12-02 |
2015-06-11 |
Gilead Pharmasset Llc |
Methods of treating hepatitis c virus infection in subjects with cirrhosis
|
TW201609785A
(zh)
|
2013-12-23 |
2016-03-16 |
吉李德製藥公司 |
固體型之抗病毒化合物
|
ES2708993T3
(es)
|
2013-12-23 |
2019-04-12 |
Gilead Sciences Inc |
Formas cristalinas de un tripéptido macrocíclico inhibidor de NS3 del VHC
|
TWI660965B
(zh)
|
2014-01-15 |
2019-06-01 |
美商基利科學股份有限公司 |
泰諾福韋之固體形式
|
US10441567B2
(en)
|
2014-01-17 |
2019-10-15 |
Ligand Pharmaceuticals Incorporated |
Methods and compositions for modulating hormone levels
|
US9463194B2
(en)
|
2014-02-05 |
2016-10-11 |
Gilead Sciences, Inc. |
Methods of treating patients co-infected with HIV and tuberculosis
|
WO2015130966A1
(en)
|
2014-02-28 |
2015-09-03 |
Gilead Sciences, Inc. |
Antiviral agents
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
WO2015179448A1
(en)
|
2014-05-21 |
2015-11-26 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
US20150361087A1
(en)
|
2014-06-12 |
2015-12-17 |
Gilead Sciences, Inc. |
Antiviral compounds
|
JP6346964B2
(ja)
|
2014-06-13 |
2018-06-20 |
ギリアード サイエンシーズ, インコーポレイテッド |
ホスファチジルイノシトール3−キナーゼ阻害剤
|
KR20170015508A
(ko)
|
2014-06-13 |
2017-02-08 |
길리애드 사이언시즈, 인코포레이티드 |
포스파티딜이노시톨 3-키나제 억제제로서의 퀴나졸리논 유도체
|
US11021467B2
(en)
|
2014-06-13 |
2021-06-01 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|
AU2015274628B2
(en)
|
2014-06-13 |
2018-03-15 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|
KR20170012557A
(ko)
|
2014-06-13 |
2017-02-02 |
길리애드 사이언시즈, 인코포레이티드 |
포스파티딜이노시톨 3-키나제 억제제
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
CN106604734B
(zh)
|
2014-06-24 |
2021-08-13 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸和其类似物
|
CN106573011A
(zh)
|
2014-06-24 |
2017-04-19 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸和其类似物
|
CN105288635A
(zh)
|
2014-06-26 |
2016-02-03 |
昆明积大制药股份有限公司 |
一种含有阿糖胞苷5’-0-氨基酸酯的药物组合物
|
WO2016007765A1
(en)
|
2014-07-11 |
2016-01-14 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors for the treatment of hiv
|
TWI678369B
(zh)
|
2014-07-28 |
2019-12-01 |
美商基利科學股份有限公司 |
用於治療呼吸道合胞病毒感染之噻吩並[3,2-d]嘧啶、呋喃並[3,2-d]嘧啶及吡咯並[3,2-d]嘧啶化合物類
|
TWI673283B
(zh)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
2’-氯胺基嘧啶酮及嘧啶二酮核苷類
|
JP6491321B2
(ja)
|
2014-08-29 |
2019-03-27 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗レトロウイルス剤
|
US20160067255A1
(en)
|
2014-09-04 |
2016-03-10 |
Gilead Sciences, Inc. |
Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir
|
EP3034499A1
(en)
|
2014-12-17 |
2016-06-22 |
Gilead Sciences, Inc. |
Novel FXR (NR1H4) modulating compounds
|
TWI738321B
(zh)
|
2014-12-23 |
2021-09-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
WO2016105534A1
(en)
|
2014-12-24 |
2016-06-30 |
Gilead Sciences, Inc. |
Isoquinoline compounds for the treatment of hiv
|
MX2017008520A
(es)
|
2014-12-24 |
2018-03-01 |
Gilead Sciences Inc |
Compuestos de pirimidina fusionada para el tratamiento del virus de inmunodeficiencia humana (vih).
|
TWI770552B
(zh)
|
2014-12-24 |
2022-07-11 |
美商基利科學股份有限公司 |
喹唑啉化合物
|
SG11201705069YA
(en)
*
|
2014-12-26 |
2017-07-28 |
Univ Emory |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
WO2016134054A1
(en)
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Anti-viral compounds
|
CU20170115A7
(es)
|
2015-03-04 |
2018-03-13 |
Gilead Sciences Inc |
Compuestos moduladores de receptor de tipo toll
|
SG11201707905WA
(en)
|
2015-04-02 |
2017-10-30 |
Gilead Sciences Inc |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
US20160303095A1
(en)
|
2015-04-14 |
2016-10-20 |
Gilead Sciences, Inc. |
Methods of treating hepatitis b virus
|
WO2016186967A1
(en)
|
2015-05-15 |
2016-11-24 |
Gilead Sciences, Inc. |
Benzimidazole and imadazopyridine carboximidamide compounds having activity as inhibitors of indoleamine 2,3-dioxygenase
|
CA2987085A1
(en)
|
2015-06-17 |
2016-12-22 |
Gilead Sciences, Inc. |
Co-crystals, salts and solid forms of tenofovir alafenamide
|
CA2921336A1
(en)
|
2015-06-30 |
2016-12-30 |
Gilead Sciences, Inc. |
Pharmaceutical formulations
|
PL3316868T3
(pl)
|
2015-06-30 |
2020-10-19 |
Gilead Sciences, Inc. |
Formulacje farmaceutyczne zawierające tenofowir i emtrycytabinę
|
JP2018523665A
(ja)
|
2015-08-06 |
2018-08-23 |
キメリックス インコーポレイテッド |
抗ウイルス剤として有用なピロロピリミジンヌクレオシドおよびその類縁体
|
AU2016312508A1
(en)
|
2015-08-26 |
2018-02-15 |
Gilead Sciences, Inc. |
Deuterated toll-like receptor modulators
|
WO2017040896A1
(en)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Anti-viral compounds
|
WO2017040895A1
(en)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Anti-viral compounds
|
US20170071944A1
(en)
|
2015-09-15 |
2017-03-16 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors for the treatment of hiv
|
EA038141B1
(ru)
|
2015-09-16 |
2021-07-13 |
Джилид Сайэнс, Инк. |
Способы лечения вирусных инфекций arenaviridae и coronaviridae
|
CA2999516A1
(en)
|
2015-09-30 |
2017-04-06 |
Gilead Sciences, Inc. |
Compounds and combinations for the treatment of hiv
|
US20190054090A1
(en)
|
2015-10-01 |
2019-02-21 |
Gilead Sciences, Inc. |
Combination of a btk inhibitor and a checkpoint inhibitor for treating cancers
|
SI3346995T1
(sl)
|
2015-11-09 |
2019-11-29 |
Gilead Sciences Inc |
Terapevtski sestavek za zdravljenje virusa človeške imunske pomanjkljivosti
|
MA44077A
(fr)
|
2015-12-15 |
2021-05-05 |
Gilead Sciences Inc |
Anticorps neutralisants le virus de l'immunodéficience humaine
|
CA3006772A1
(en)
|
2015-12-17 |
2017-06-22 |
Gilead Sciences, Inc. |
Tank-binding kinase inhibitor compounds
|
US10874683B2
(en)
|
2016-03-10 |
2020-12-29 |
Emory University |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
WO2017165489A1
(en)
*
|
2016-03-23 |
2017-09-28 |
Emory University |
Antiviral agents for treating zika and dengue virus infections
|
KR20180128016A
(ko)
|
2016-04-08 |
2018-11-30 |
크리스탈 바이오테크, 인크. |
피부의 상처, 장애 및 질환의 치료를 위한 조성물 및 방법
|
WO2017184668A1
(en)
|
2016-04-20 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating flaviviridae virus infections
|
WO2017184670A2
(en)
|
2016-04-22 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating zika virus infections
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
US11738013B2
(en)
|
2016-05-27 |
2023-08-29 |
Gilead Sciences, Inc. |
Methods for treating hepatitis B virus infections using NS5A, NS5B or NS3 inhibitors
|
WO2017223020A1
(en)
|
2016-06-20 |
2017-12-28 |
Merck Sharp & Dohme Corp. |
Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
WO2017223268A1
(en)
|
2016-06-22 |
2017-12-28 |
Yale University |
COMPOSITIONS AND METHODS OF RESENSITIZING CELLS TO BROMODOMAIN AND EXTRATERMINAL DOMAIN PROTEIN INHIBITORS (BETi)
|
GB2590198B
(en)
*
|
2017-12-07 |
2022-02-23 |
Univ Emory |
N4-hydroxycytidine derivatives and anti-viral uses related thereto
|
KR20200140274A
(ko)
|
2018-03-07 |
2020-12-15 |
에모리 유니버시티 |
4'-할로겐 함유 뉴클레오티드 및 뉴클레오시드 치료 조성물 및 이와 관련된 용도
|
JP2023512666A
(ja)
|
2020-02-07 |
2023-03-28 |
エモリー ユニバーシティー |
N4-ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
|